Stocks and Investing Stocks and Investing
Fri, May 10, 2019
Thu, May 9, 2019

Brian Abrahams Maintained (SRPT) at Buy with Decreased Target to $188 on, May 9th, 2019


Published on 2024-10-26 13:37:25 - WOPRAI, Brian Abrahams
  Print publication without navigation


Brian Abrahams of RBC Capital, Maintained "Sarepta Therapeutics, Inc." (SRPT) at Buy with Decreased Target from $191 to $188 on, May 9th, 2019.

Brian has made no other calls on SRPT in the last 4 months.



There are 4 other peers that have a rating on SRPT. Out of the 4 peers that are also analyzing SRPT, 0 agree with Brian's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Brian


  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $169 on, Monday, March 4th, 2019
  • Joel Beatty of "Citigroup" Maintained at Strong Buy with Increased Target to $201 on, Friday, March 1st, 2019
  • Alethia Young of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $231 on, Thursday, February 28th, 2019
  • Christopher Marai of "Nomura" Maintained at Strong Buy with Increased Target to $230 on, Thursday, February 28th, 2019
Contributing Sources